Medical implant sales in the US are driven by a growing prevalence of chronic orthopedic, cardiovascular, neuro- logical, ophthalmic, hearing loss, and various other conditions that are not responsive to pharmaceutical or less invasive surgical therapies.
Lifestyles affect sales growth
A rising incidence of injuries attributable to the expansion of sports activities, the increasing adoption of exercise- active lifestyles, and the high vulnerability of elderly individuals to falls and other accidents will broaden revenue opportunities for bone substitutes, tissue implants, and internal fixation devices employed in spinal fusion, trauma treatment, and fracture repair. Demand for the orthobiologic hyaluronic acid will advance at a fast pace based on widening use in osteoarthritis therapy and cosmetic surgery. Lastly, demand for dental implants will see sizeable gains as the prevalence of serious tooth and gum diseases in the aging population rises and the avail- ability of affordable dental insurance improves.
Orthopedics to remain top-selling group
Orthopedic products will remain the top-selling group of medical implants, with total demand advancing over five percent annually. A combination of demographic, lifestyle, and epidemiological trends will promote growth. The aging of the population will boost the prevalence of degenerative musculoskeletal conditions often requiring reconstructive joint replacement and/or spinal surgery.
Cardiac implants will generate growth
The second-largest selling group of medical implants treats or manages various types of heart disease. Revenues generated by cardiac implants will be spread fairly evenly among three major product lines -- pacing devices, cardiac stents and related implants, and structural cardiac implants. Structural cardiac implants will generate the fastest growth in demand value due to upward trends in the prevalence of vavular heart disease and the increasing use of high value-added tissue-based replacement valves. By contrast, sales of pacing devices will grow slowly as advances in pharmaceuticals and surgical therapies eliminate the need for implants in some patients afflicted with heart rhythm disorders. Lastly, a heightened level of coronary and peripheral artery diseases will boost the market for cardiac stents and related products.
Medical Implants in the US (Orthopedic, Cardiac & Other), 6th Edition presents historical demand data (2005, 2010 and 2015) plus forecasts (2020 and 2025) for orthopedic (e.g., reconstructive joint replacements, spinal implants, orthobiologics), cardiac (e.g., stents and related implants, pacing devices) and other medical implants (e.g., gastroenterologicals, urologicals, cosmetics).